Further analysis showed that CEP55 was significantly upregulated in triple-negative breast cancers compared to other types of breast cancers, including luminal and HER2-positive cancers, demonstrating CEP55 may have a regulatory role in TNBC. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.